Hebei Alheal Pharmaceutical

Alheal Pharmaceutical (Hainan Aohe Pharmaceutical Co., Ltd.) is a Chinese pharmaceutical company that operates as the dedicated sales, marketing, and academic promotion platform for its parent group, Wutai Pharmaceutical Technology Co., Ltd. The company manages the commercialization and market research of the group's drug portfolio, which is developed by sister CRO Jinan Kanghe Pharmaceutical and manufactured by Shandong Lusure Pharmaceutical. Alheal's product focus spans key therapeutic areas such as cardiovascular health, respiratory therapies, antifungals, and vitamins. Notably, the company is involved in the commercialization of indobufen tablets, a small molecule antiplatelet agent targeting cyclooxygenase for cardiovascular indications.